Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells-Reference-Cited by-同舟云学术

Soluble Antigen Arrays for Selective Desensitization of Insulin-Reactive B Cells

Published:2019-01-25 Issue:4 Volume:16 Page:1563-1572
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Leon Martin A.¹^ORCID,Wemlinger Scott M.²,Larson Nicholas R.³^ORCID,Ruffalo Justin K.⁴,Sestak Joshua O.⁵,Middaugh C. Russell³,Cambier John C.²,Berkland Cory¹³⁴^ORCID

Affiliation:

1. Department of Chemistry, University of Kansas, 1251 Wescoe Hall Drive, Lawrence, Kansas 66045, United States

2. Department Immunology & Microbiology, University of Colorado Denver AMC, 12800 E. 19th Ave., Aurora, Colorado 80045, United States

3. Department of Pharmaceutical Chemistry, University of Kansas, 2095 Constant Avenue, Lawrence, Kansas 66047, United States

4. Department of Chemical and Petroleum Engineering, University of Kansas, 1530 West 15th Street, Lawrence, Kansas 66045, United States

5. Orion BioScience, 986099 Nebraska Medical Center, Omaha, Nebraska 68198, United States

Funder

Macromolecule and Vaccine Stabilization Center, University of Kansas

Nuclear Magnetic Resonance Laboratory, University of Kansas

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.8b01250

Reference38 articles.

1. Interview: Experiences targeting B cells for the treatment of multiple sclerosis

2. Targeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges

3. Investigation of the Role of B-Cells in Type 1 Diabetes in the NOD Mouse

4. The preferential ability of B lymphocytes to act as diabetogenic APC in NOD mice depends on expression of self-antigen-specific immunoglobulin receptors

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering antigen-presenting cells for immunotherapy of autoimmunity;Advanced Drug Delivery Reviews;2024-07

2. Factors Governing B Cell Recognition of Autoantigen and Function in Type 1 Diabetes;Antibodies;2024-04-01

3. Latest advancements in the development of new therapies for type 1 diabetes;Bratislava Medical Journal;2024

4. Biomaterial engineering strategies for B cell immunity modulations;Biomaterials Science;2024

5. Cell and biomaterial delivery strategies to induce immune tolerance;Advanced Drug Delivery Reviews;2023-12